HBI Deals+Insights / M&A/IPOs
Private equity firm CVC, through its mid-market fund CVC Catalyst III, is buying US-based prosthetics maker WillowWood from private equity firm Blue Sea Capital. A key aspect of CVC’s strategy post-acquisition is to expand WillowWood’s presence in Europe and build a direct commercial footprint in the region.





